article · Egyptian Journal of Veterinary Science
he study aimed to investigate the potential anti-ageing effects of melatonin on the liver, kidney, and brain in rats with accelerated ageing induced by aluminum chloride (AlCl3) and D-galactose. Fifteen male albino Wistar rats were divided into three groups: a control group receiving normal saline, an accelerated ageing group receiving AlCl3 and D-galactose, and a melatonin-treated group receiving AlCl3, D-galactose, and melatonin. biochemical markers such as serum transaminases, oxidant /antioxidant enzymes, TNF-α, Bax and Bcl2 proteins, IL6 and SASP expression, and histopathological changes were assessed. Melatonin treatment mitigated hepatorenal and neural impairment in the aged rat group by reducing ALT, AST, urea, creatinine, TNF-α, and MDA levels. It also enhanced SOD activity and increased Bcl-2 levels while decreasing Bax and IL6/SASP expression. These findings suggest that melatonin may have therapeutic potential against oxidative stress and histopathological changes associated with ageing, likely due to its antioxidant, anti-apoptotic, and anti-inflammatory properties. Therefore, melatonin could be considered a protective agent against AlCl3 and D-galactose-induced ageing in rats
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/ejvs.2024.277314.1925
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
